Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: RISPERIDONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for risperidone from Sun Pharmaceutical Industries, Inc., indicating an update to labeling or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)